FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture

FDA Approves New Treatment of Osteoporosis In Postmenopausal Women At High Risk For Fracture

A new treatment was recently approved by the FDA to help women at high risk for fracture reduce their risk of a first and subsequent fracture.

Menopause & Aging Well

Postmenopausal osteoporosis is a significant and women's health issue that far too often gets overlooked, despite being common. One in two women will experience a fracture due to osteoporosis in her lifetime, and these fractures can be devastating, with many leading to hospital stays and life-altering consequences.


A new treatment was recently approved by the FDA to help women at high risk for fracture reduce their risk of a first and subsequent fracture.

CLICK HERE To learn more about this new treatment option.

You might be interested in